These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22130178)

  • 1. Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.
    Seo JS; Jamieson K; Cosgrove V; Gwizdowski IS; Yang H; Sheehan DV; McElroy SL; Suppes T
    Eur Psychiatry; 2013 Mar; 28(3):190-6. PubMed ID: 22130178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
    Sheehan DV; Harnett-Sheehan K; Hidalgo RB; Janavs J; McElroy SL; Amado D; Suppes T
    J Affect Disord; 2013 Feb; 145(1):83-94. PubMed ID: 22920718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.
    Brawman-Mintzer O; Knapp RG; Nietert PJ
    J Clin Psychiatry; 2005 Oct; 66(10):1321-5. PubMed ID: 16259547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label trial of risperidone augmentation for refractory anxiety disorders.
    Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH
    J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
    Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
    Hirschfeld RM; Eerdekens M; Kalali AH; Canuso CM; Khan AA; Karcher K; Palumbo JM
    Int Clin Psychopharmacol; 2006 Jan; 21(1):11-20. PubMed ID: 16317312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.
    Pandina GJ; Canuso CM; Turkoz I; Kujawa M; Mahmoud RA
    Psychopharmacol Bull; 2007; 40(3):41-57. PubMed ID: 18007568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.
    Prosser JM; Yard S; Steele A; Cohen LJ; Galynker II
    BMC Psychiatry; 2009 May; 9():25. PubMed ID: 19470174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.
    Gopal S; Steffens DC; Kramer ML; Olsen MK
    J Clin Psychiatry; 2005 Aug; 66(8):1016-20. PubMed ID: 16086617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.
    Keck PE; Strawn JR; McElroy SL
    J Clin Psychiatry; 2006; 67 Suppl 1():8-15. PubMed ID: 16426111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.
    Khanna S; Vieta E; Lyons B; Grossman F; Eerdekens M; Kramer M
    Br J Psychiatry; 2005 Sep; 187():229-34. PubMed ID: 16135859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
    J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.